Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman : A case report

Copyright © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved..

Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfunction (i.e., cardiovascular and mucocutaneous involvement) and markedly elevated inflammatory markers 2 weeks after recovery from COVID-19. Treatment with intravenous immunoglobulins and corticosteroids resolved her symptoms. On the 13th day, she was discharged from the hospital with no recurrences on follow-up. This study highlights the importance of recognizing this emerging syndrome when treating patients with multiorgan dysfunction after COVID-19.

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - Vol. 28, No. 1 (2021), p. 99-102

Language:

English

Contributors:

Miyamoto, Kyohei
Koizumi, Yusuke
Tamura, Shinobu
Nakashima, Tsuyoshi
Kobai, Kaori
Tanaka, Rikako
Shibata, Mami
Shima, Nozomu
Nemoto, Shigeki
Fukumoto, Nobu
Kato, Seiya

Links:

Volltext

Keywords:

COVID-19
Journal Article
Multisystem inflammatory syndrome
SARS-CoV-2

Notes:

Date Revised 18.11.2021

published: Print-Electronic

Citation Status In-Process

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1016/j.jiac.2021.09.014

PMID:

34620535

PPN (Catalogue-ID):

NLM33275023X